Treatment effects | No of scans4-150 | Statistical powers | ||||||
---|---|---|---|---|---|---|---|---|
80% | 90% | |||||||
Group A | Group B | Group C | Group A | Group B | Group C | |||
20% | 3 | 80 | 60 | 82 | 108 | 75 | 100 | |
6 | 48 | 35 | 62 | 60 | 52 | 72 | ||
30% | 3 | 42 | 30 | 50 | 50 | 40 | 67 | |
6 | 22 | 21 | 35 | 32 | 32 | 44 | ||
40% | 3 | 26 | 19 | 29 | 35 | 28 | 40 | |
6 | 14 | 12 | 20 | 20 | 18 | 28 | ||
50% | 3 | 18 | 12 | 21 | 25 | 18 | 29 | |
6 | 12 | 9 | 16 | 17 | 12 | 21 |
↵4-150 These are numbers of scans for each of the portions of the trial.
Group A: patients with RRMS not selected for MRI activity at entry;
Group B: patients with RRMS selected for MRI activity at entry;
Group C: patients with SPMS not selected for MRI activity at entry.
For further details and statistical analysis: see text.